Mesa Laboratories to report Q4 and full fiscal year 2026 results on May 27, 2026

Mesa Laboratories, a global leader in life science tools, will release its financial results for the fourth quarter and full fiscal year ending March 31, 2026, on May 27, 2026. This announcement is important for investors tracking the company's performance in pharmaceutical and healthcare quality control markets. The results will provide insights into Mesa's business health and future prospects under its new CEO Siddhartha Kadia, appointed earlier in 2026.